Original paper
Clinical and Economic Value of Genetic Sequencing for Personalized Therapy in Non–small-cell Lung Cancer
Abstract
Two recent studies examining the clinical and economic value of next-generation sequencing (NGS)-based diagnostic testing (multi-gene panel examining ≥ 30 genes) for non–small-cell lung cancer therapy compared with single gene ALK, EGFR testing to select therapy demonstrated statistically insignificant improvement in population-level overall survival and only a moderate incremental cost-effectiveness ratio associated with the NGS testing...
Paper Details
Title
Clinical and Economic Value of Genetic Sequencing for Personalized Therapy in Non–small-cell Lung Cancer
Published Date
Nov 1, 2020
Journal
Volume
21
Issue
6
Pages
477 - 481
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History